GSK transfers malaria vaccine production to India's Bharat Biotech

The agreement includes transfer of manufacturing of the protein part of the vaccine, RTS,S/AS01, while GSK will continue to supply Bharat Biotech with the adjuvant or vaccine booster for the shot, the London-listed company said.
Source: The Economic Times - Category: Consumer Health News Source Type: news